Key Market Indicators
Sales of antihypertensive medicines in Austria are projected to reach $59 million by 2026, a 0.5% year-on-year growth rate. Since 2015, the demand for these medicines in the country has risen 1.7% annually. Austria was in sixth place in 2021, slightly behind Canada's $58.52 million. Italy, Spain and Australia ranked second, third and fourth respectively.
